PROSTATIC NEOPLASM
Clinical trials for PROSTATIC NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for men battling prostate cancer a second time
Disease control CompletedThis study tested a new, highly focused type of radiation for men whose prostate cancer returned after previous radiation treatment. The goal was to find the safest, most effective dose of this 5-session treatment, called stereotactic body radiation therapy (SBRT). Researchers al…
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New tool aims to protect cancer Survivors' hearts
Disease control CompletedThis study tested a computer tool that automatically shows a cancer survivor's heart health risks using their existing medical records. The goal was to see if this tool helped survivors and their cancer doctors have better conversations about heart health, leading to more referra…
Matched conditions: PROSTATIC NEOPLASM
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo tested to delay prostate cancer progression
Disease control CompletedThis study tested whether adding two drugs, abiraterone acetate and prednisone, to standard hormone therapy could better control advanced prostate cancer that had not yet spread to other body parts. It involved 131 men whose cancer was resistant to standard hormone treatment but …
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE2 • Sponsor: Janssen Biotech, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Radioactive drug trial offers new hope for men with Tough-to-Treat prostate cancer
Disease control CompletedThis study tested whether adding a radioactive drug (I-131-1095) to standard medication (enzalutamide) could better control advanced prostate cancer that had worsened on a prior drug (abiraterone). It involved 120 men whose cancer had spread and was visible on a special PSMA scan…
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists test 'Double Radiation' attack on tough prostate cancer
Disease control CompletedThis early-stage study tested whether adding a newer, targeted radiation drug (Lu-PSMA) to standard radiation therapy (EBRT) is safe and tolerable for men with prostate cancer that has spread to nearby lymph nodes. The goal was to see if this combination could better control the …
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC